METROPOLITAN LIFE INSURANCE CO/NY - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of NOVOCURE LTD
ValueSharesWeighting
Q4 2021$511,295
-35.9%
6,810
-0.8%
0.01%
-41.7%
Q3 2021$797,275
-17.6%
6,863
-6.3%
0.01%
-14.3%
Q1 2021$967,822
-26.9%
7,322
-4.3%
0.01%
-30.0%
Q4 2020$1,324,102
+182.8%
7,652
-3.1%
0.02%
+150.0%
Q2 2020$468,233
-77.2%
7,896
-71.3%
0.01%
-77.1%
Q3 2019$2,055,702
+38.6%
27,490
+17.2%
0.04%
+40.0%
Q2 2019$1,482,680
+31.3%
23,4490.0%0.02%
+25.0%
Q1 2019$1,129,53823,4490.02%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders